{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:31:34Z","timestamp":1781605894600,"version":"3.54.5"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"Importance<\/jats:title>Infrequent intraprocedural premature ventricular complexes (PVCs) limit the efficacy of catheter ablation. Intravascular stimulation of sympathetic nerves via vertebral veins (VVs) has been used to activate cardiac sympathetic tone and may promote PVCs.<\/jats:p><\/jats:sec>Objective<\/jats:title>To characterize the ability of direct electrical sympathetic stimulation via VVs to induce PVCs at the time of catheter ablation.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This prospective case series involved adult patients undergoing catheter ablation of PVCs, with rare or absent PVCs despite standard provocation, at the Hospital of the University of Pennsylvania between 2022 and 2024. Stimulation was performed via the left VV (20 Hz, up to 25 mA).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was PVC frequency, assessed before, during, and after stimulation. A multilevel mixed-effects Poisson regression was used to compare the rate of PVCs during the procedure.<\/jats:p><\/jats:sec>Results<\/jats:title>Fifteen patients (mean [SD] age, 60\u2009[17] years; 10 male [71%]) had a mean (SD) preprocedure PVC burden of 16.3%\u2009(8.6%) (median [IQR], 17.0% [11.5%-21.5%]), and 7 of 15 had undergone at least 1 prior unsuccessful ablation. Provocation of PVCs was attempted with isoproterenol, atrial and ventricular burst pacing, and minimal sedation in all patients before VV stimulation. Throughout the 10-minute period before VV stimulation, patients had a mean (SD) of 1.3\u2009(1.4) PVCs (median [IQR], 1.0 [0.0-2.5] PVCs). During VV stimulation, PVCs were noted in all patients (mean [SD], 8.2\u2009[5.7] PVCs per minute; median [IQR], 6.0 [4.5-13.0] PVCs per minute). In the 10-minute period after VV stimulation, patients had a mean (SD) of 5.1\u2009(6.6) PVCs per minute (median [IQR], 3.0 [0.5-6.5] PVCs per minute). After VV stimulation, ablation was guided by activation mapping in 7 patients and by pace mapping alone in the remaining patients. Postablation monitoring demonstrated a mean (SD) 1.3%\u2009(2.3%) burden of PVCs (median [IQR], 0.0% [0.0%-2.5%]), with 9 of 15 patients having less than 1% burden of PVCs. There were no adverse events related to VV stimulation.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that intravascular sympathetic stimulation via the VV can be used to safely provoke PVCs during catheter ablation.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2024.4447","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T16:03:39Z","timestamp":1734969819000},"page":"207","source":"Crossref","is-referenced-by-count":3,"title":["Intravascular Sympathetic Stimulation to Facilitate Catheter Ablation of Premature Ventricular Complexes"],"prefix":"10.1001","volume":"10","author":[{"given":"Timothy M.","family":"Markman","sequence":"first","affiliation":[{"name":"Section for Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory M.","family":"Tschabrunn","sequence":"additional","affiliation":[{"name":"Section for Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Callans","sequence":"additional","affiliation":[{"name":"Section for Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[{"name":"Section for Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Nazarian","sequence":"additional","affiliation":[{"name":"Section for Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"hoi240073r1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz132","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.","volume":"21","author":"Cronin","year":"2019","journal-title":"Europace"},{"issue":"2","key":"hoi240073r2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","article-title":"Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study.","volume":"7","author":"Ling","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"17","key":"hoi240073r3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.119.042434","article-title":"Evaluation and management of premature ventricular complexes.","volume":"141","author":"Marcus","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"hoi240073r4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jacep.2023.01.035","article-title":"Catheter ablation vs antiarrhythmic drug therapy for treatment of premature ventricular complexes: a systematic review.","volume":"9","author":"De Silva","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"hoi240073r5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1540-8159.1982.tb02190.x","article-title":"Frequency and variability of ventricular premature contractions\u2014the influence of heart rate and circadian rhythms.","volume":"5","author":"Steinbach","year":"1982","journal-title":"Pacing Clin Electrophysiol"},{"issue":"21","key":"hoi240073r6","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1001\/jama.2020.3833","article-title":"Case series of transcutaneous magnetic stimulation for ventricular tachycardia storm.","volume":"323","author":"Markman","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"hoi240073r7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jamacardio.2021.6000","article-title":"Effect of transcutaneous magnetic stimulation in patients with ventricular tachycardia storm: a randomized clinical trial.","volume":"7","author":"Markman","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"2","key":"hoi240073r8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacep.2022.08.031","article-title":"Neuromodulation for the treatment of refractory ventricular arrhythmias.","volume":"9","author":"Markman","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"10","key":"hoi240073r9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/jce.12454","article-title":"Infrequent intraprocedural premature ventricular complexes: implications for ablation outcome.","volume":"25","author":"Baser","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"hoi240073r10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.hrthm.2017.07.034","article-title":"Circadian variability patterns predict and guide premature ventricular contraction ablation procedural inducibility and outcomes.","volume":"15","author":"Hamon","year":"2018","journal-title":"Heart Rhythm"},{"issue":"4","key":"hoi240073r11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/pace.14211","article-title":"Pre-procedural arrhythmia burden and the outcome of catheter ablation of idiopathic premature ventricular complexes.","volume":"44","author":"Asatryan","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"issue":"23","key":"hoi240073r12","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.jacc.2017.10.031","article-title":"Catheter ablation of ventricular tachycardia in structurally normal hearts: indications, strategies, and outcomes\u2014part I.","volume":"70","author":"Dukkipati","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi240073r13","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1111\/jce.14127","article-title":"Catheter ablation of premature ventricular complexes with low intraprocedural burden guided exclusively by pace-mapping.","volume":"30","author":"Shirai","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"hoi240073r14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcm.2018.09.014","article-title":"Treatment of ventricular arrhythmias: what\u2019s new?","volume":"29","author":"Markman","year":"2019","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"hoi240073r15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/europace\/euaa069","article-title":"Oral caffeine intake amplifies the effect of isoproterenol in patients with frequent premature ventricular contractions.","volume":"22","author":"Hasebe","year":"2020","journal-title":"Europace"},{"issue":"2","key":"hoi240073r16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10840-011-9652-3","article-title":"Isoproterenol infusion increases level of consciousness during catheter ablation of atrial fibrillation.","volume":"34","author":"O\u2019Neill","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"issue":"5","key":"hoi240073r17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10840-022-01448-x","article-title":"Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.","volume":"66","author":"Aldaas","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"hoi240073r18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1540-8167.2012.02386.x","article-title":"Idiopathic right ventricular tract outflow tachycardia induced by high-frequency stimulation.","volume":"24","author":"Jesuraj","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"hoi240073r19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1540-8167.2009.01442.x","article-title":"Human model simulating right ventricular outflow tract tachycardia by high-frequency stimulation in the left pulmonary artery: autonomics and idiopathic ventricular arrhythmias.","volume":"20","author":"Hasdemir","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7 Pt 1","key":"hoi240073r20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jacep.2023.03.005","article-title":"Feasibility of intravascular cervical sympathetic nerve stimulation.","volume":"9","author":"Markman","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"hoi240073r21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCEP.123.012063","article-title":"Physiologic effects of right-sided intravascular cervical sympathetic nerve stimulation.","volume":"16","author":"Markman","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7 Pt 2","key":"hoi240073r22","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.jacep.2024.04.021","article-title":"Right vertebral vein stimulation for induction of premature atrial complexes enabling successful mapping and ablation.","volume":"10","author":"Petzl","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"hoi240073r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2024.08.006","article-title":"Augmentation of atrial conduction velocity with pharmacological and direct electrical sympathetic stimulation.","author":"Markman","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"hoi240073r24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0014-2999(02)01889-7","article-title":"Pharmacology of neuropeptide Y receptor antagonists: focus on cardiovascular functions.","volume":"447","author":"Malmstr\u00f6m","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"hoi240073r25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2796.1990.tb00283.x","article-title":"Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man.","volume":"228","author":"Ullman","year":"1990","journal-title":"J Intern Med"},{"issue":"24","key":"hoi240073r26","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/eurheartj\/ehz115","article-title":"Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.","volume":"40","author":"Herring","year":"2019","journal-title":"Eur Heart J"},{"issue":"11","key":"hoi240073r27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/jci.insight.135519","article-title":"Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.","volume":"5","author":"Hoang","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"hoi240073r28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/01.HYP.14.2.177","article-title":"Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings.","volume":"14","author":"Anderson","year":"1989","journal-title":"Hypertension"},{"key":"hoi240073r29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fnins.2016.00614","article-title":"Heart rate changes in response to mechanical pressure stimulation of skeletal muscles are mediated by cardiac sympathetic nerve activity.","volume":"10","author":"Watanabe","year":"2017","journal-title":"Front Neurosci"},{"issue":"6","key":"hoi240073r30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1113\/expphysiol.2007.039545","article-title":"A sympathetic view of the sympathetic nervous system and human blood pressure regulation.","volume":"93","author":"Joyner","year":"2008","journal-title":"Exp Physiol"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2828584\/jamacardiology_markman_2024_oi_240073_1741367272.53785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:01:15Z","timestamp":1741791675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2828584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.4447","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}